Literature DB >> 14586716

The involvement of advanced glycation endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and infiltration of immune cells.

Yonghui Mao1, Tetsuya Ootaka, Takao Saito, Hiroshi Sato, Toshinobu Sato, Sadayoshi Ito.   

Abstract

BACKGROUND: Glycation of proteins is regarded as one of the major causes of the progression of diabetic nephropathy (DN) and of the phenotypic changes in glomerular mesangial cells (MC) and the cellular infiltration that occurs in MC from DN. It thus is very important to study the interrelationships and interaction between these causes.
METHODS: The localization of advanced glycation endproducts (AGEs), cytoskeletal proteins, and immune cell infiltration was evaluated by immunohistochemical study in patients with DN.
RESULTS: N(Epsilon)-(carboxymethyl)lysine (CML), Alpha-smooth muscle actin (SMA), and low-molecular-weight caldesmon (L-CLD) were localized in the mesangial area in DN. The intensity of mesangial SMA and L-CLD expression was significantly correlated with the index of diabetic glomerulosclerosis (IDGS), while the expression of pentosidine was correlated with the IDGS and with 24-h urinary protein. Pentosidine was localized in glomerular basement membrane (GBM) only in DN and had a significant correlation with the mesangial expression of SMA and L-CLD. Pyrraline deposition on the tubular basement membrane, and the expression of SMA and L-CLD, and the infiltration of immune cells were observed in interstitial areas in DN. The intensity of L-CLD expression had a close relationship with pyrraline deposition and immune cell infiltration. The expression of SMA and L-CLD in interstitial areas was significantly correlated with the percent interstitial volume.
CONCLUSIONS: AGEs are involved in renal injury in DN, and their effect is, at least in part, exercised via phenotypic changes in intrinsic renal cells and by the infiltration of immune cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586716     DOI: 10.1007/s10157-003-0245-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  5 in total

1.  AGEs-RAGE overexpression in a patient with smoking-related idiopathic nodular glomerulosclerosis.

Authors:  Nao Nakamura; Kensei Taguchi; Yoshihiro Miyazono; Keiichiro Uemura; Kiyomi Koike; Yuka Kurokawa; Yosuke Nakayama; Yusuke Kaida; Ryo Shibata; Akihiro Tsuchimoto; Katsuhiko Asanuma; Kei Fukami
Journal:  CEN Case Rep       Date:  2017-11-27

2.  Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial.

Authors:  Xu Lengnan; Zhao Ban; Wang Haitao; Liu Lili; Chen Aiqun; Wang Huan; Zeng Ping; Mao Yonghui
Journal:  Biomed Res Int       Date:  2020-06-10       Impact factor: 3.411

3.  Demethylzeylasteral reduces the level of proteinuria in diabetic nephropathy: Screening of network pharmacology and verification by animal experiment.

Authors:  Lengnan Xu; Ban Zhao; Liping Yang; Xinyi Dong; Xue Yang; Yonghui Mao
Journal:  Pharmacol Res Perspect       Date:  2022-08

4.  Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice.

Authors:  Hajime Nagasu; Minoru Satoh; Emi Kiyokage; Kengo Kidokoro; Kazunori Toida; Keith M Channon; Yashpal S Kanwar; Tamaki Sasaki; Naoki Kashihara
Journal:  Lab Invest       Date:  2015-11-09       Impact factor: 5.662

5.  Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells.

Authors:  Catharine Whiteside; Hong Wang; Ling Xia; Snezana Munk; Howard J Goldberg; I George Fantus
Journal:  Exp Diabetes Res       Date:  2009-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.